Idecabtagene Vicleucel (ide-cel) versus Standard (std) Regimens in Patients (pts) with Triple-class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): Updated Analysis from KarMMa-3

被引：0

作者：

Scheid, Christoph ^{[1
]}

Rodriguez-Otero, Paula ^{[2
]}

Ailawadhi, Sikander ^{[3
]}

Arnulf, Bertrand ^{[4
]}

Patel, Krina ^{[5
]}

Cavo, Michele ^{[6
]}

Nooka, Ajay K. ^{[7
]}

Manier, Salomon ^{[8
]}

Callander, Natalie ^{[9
]}

Costa, Luciano J. ^{[10
]}

Vij, Ravi ^{[11
]}

Bahlis, Nizar J. ^{[12
]}

Moreau, Philippe ^{[13
]}

Solomon, Scott R. ^{[14
]}

Abrahamsen, Ingerid Weum ^{[15
]}

Baz, Rachid ^{[16
]}

Broijl, Annemiek ^{[17
]}

Chen, Christine ^{[18
]}

Jagannath, Sundar ^{[19
]}

Raje, Noopur ^{[20
]}

Delforge, Michel ^{[21
]}

Benjamin, Reuben ^{[22
]}

Pabst, Thomas ^{[23
]}

Iida, Shinsuke ^{[24
]}

Berdeja, Jesus ^{[25
]}

Truppel-Hartmann, Anna ^{[26
]}

Bhatnagar, Rashmi ^{[27
]}

Wu, Fan ^{[28
]}

Piasecki, Julia ^{[28
]}

Eliason, Laurie ^{[28
]}

Dhanda, Devender ^{[28
]}

Felten, Jasper ^{[28
]}

Caia, Andrea ^{[28
]}

Cook, Mark ^{[29
]}

Mckiver, Mihaela Popa ^{[28
]}

Giralt, Sergio ^{[30
]}

机构：

[1] Univ Cologne, Cologne, Germany

[2] Clin Univ Navarra, Pamplona, Spain

[3] Mayo Clin, Jacksonville, FL USA

[4] Univ Paris Cite, Paris, France

[5] Univ Texas Houston, Houston, TX USA

[6] Bologna Univ, Sch Med, Bologna, Italy

[7] Emory Univ, Atlanta, GA USA

[8] Univ Lille, Lille, France

[9] Univ Wisconsin, Madison, WI USA

[10] Univ Alabama Birmingham, Birmingham, AL USA

[11] Washington Univ, Sch Med St Louis, St Louis, MO USA

[12] Univ Calgary, Calgary, AB, Canada

[13] Univ Hosp Nantes, Nantes, France

[14] Northside Hosp Canc Inst, Atlanta, GA USA

[15] Oslo Univ Hosp, Oslo, Norway

[16] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[17] Erasmus MC Canc Inst, Rotterdam, Netherlands

[18] Princess Margaret Hosp, Toronto, ON, Canada

[19] Mt Sinai Med Ctr, New York, NY USA

[20] Massachusetts Gen Hosp, Boston, MA USA

[21] Univ Ziekenhuizen Leuven, Leuven, Belgium

[22] Kings Coll Hosp London, London, England

[23] Bern Univ Hosp, Bern, Switzerland

[24] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan

[25] Sarah Cannon Res Inst, Nashville, TN USA

[26] 2seventy Bio, Cambridge, MA USA

[27] Syneos Hlth, Gurugram, Haryana, India

[28] Bristol Myers Squibb, Princeton, NJ USA

[29] Bristol Myers Squibb, Boudry, Switzerland

[30] Mem Sloan Kettering Canc Ctr, New York, NY USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1060

引用

页码：247 / 248

页数：2

共 50 条

[1] Idecabtagene Vicleucel (ide-cel) Versus Standard (std) Regimens in Patients (pts) with Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): Updated Analysis from KarMMa-3
Rodriguez Otero, Paula
Ailawadhi, Sikander
Arnulf, Bertrand
Patel, Krina K.
Cavo, Michele
Nooka, Ajay K.
Manier, Salomon
Callander, Natalie S.
Costa, Luciano
Vij, Ravi
Bahlis, Nizar J.
Moreau, Philippe
Solomon, Scott R.
Abrahamsen, Ingerid Weum
Baz, Rachid
Broijl, Annemiek
Chen, Christine
Jagannath, Sundar
Raje, Noopur S.
Scheid, Christof
Delforge, Michel
Benjamin, Reuben
Pabst, Thomas
Iida, Shinsuke
Berdeja, Jesus G.
Truppel-Hartmann, Anna
Bhatnagar, Rashmi
Wu, Fan
Piasecki, Julia
Eliason, Laurie
Dhanda, Devender
Felten, Jasper
Caia, Andrea
Cook, Mark
Popa-McKiver, Mihaela
Giralt, Sergio A.
BLOOD, 2023, 142
[2] Idecabtagene Vicleucel (ide-cel) Versus Standard (std) Regimens in Patients (pts) with Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): Analysis of Cytopenias and Infections in Pts from KarMMa-3
Baz, Rachid
Otero, Paula Rodriguez
Ailawadhi, Sikander
Arnulf, Bertrand
Patel, Krina K.
Nooka, Ajay K.
Costa, Luciano
Raje, Noopur S.
Abrahamsen, Ingerid Weum
Delforge, Michel
Gergis, Usama
Sborov, Douglas W.
Giralt, Sergio A.
Raab, Marc S.
Ishida, Tadao
Varshavsky-Yanovsky, Asya
Choi, Taewoong
Larry, Anderson D., Jr.
Truppel-Hartmann, Anna
Bhatnagar, Rashmi
Wu, Fan
Piasecki, Julia
Felten, Jasper
Caia, Andrea
Cook, Mark
Lin, Yi
BLOOD, 2023, 142
[3] Idecabtagene vicleucel (ide-cel) versus standard (std) regimens in triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 subgroup analysis in patients (pts) receiving bridging therapy
Einsele, Hermann
Rodriguez-Otero, Paula
Arnulf, Bertrand
Patel, Krina
Manier, Salomon
Costa, Luciano J.
Bahlis, Nizar J.
Broijl, Annemiek
Chen, Christine
Abrahamsen, Ingerid Weum
Delforge, Michel
Gergis, Usama
Raab, Marc S.
Singhal, Seema
Abonour, Rafat
Truppel-Hartmann, Anna
Bhatnagar, Rashmi
Felten, Jasper
Caia, Andrea
Wu, Fan
Piasecki, Julia
Cook, Mark
Ailawadhi, Sikander
ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 141 - 142
[4] Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens in Patients With Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): A KarMMa-3 Analysis in High-Risk Subgroups
Patel, Krina
Rodriguez-Otero, Paula
Manier, Salomon
Baz, Rachid
Raab, Mark-Steffen
Cavo, Michele
Callander, Natalie
Costa, Luciano J.
Moreau, Phillippe
Solomon, Scott
Chen, Christine
Raje, Noopur
Scheid, Christoph
Delforge, Michel
Larsen, Jeremy
Pabst, Thomas
Suzuki, Kenshi
Truppel-Hartmann, Anna
Yang, Zhihong
Piasecki, Julia
Felten, Jasper
Caia, Andrea
Cook, Mark
Giralt, Sergio
Mateos, Maria-Victoria
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S497 - S498
[5] Idecabtagene vicleucel (ide-cel) versus standard regimens in patients with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): a KarMMa-3 high-risk subgroup analysis
Patel, Krina
Rodriguez-Otero, Paula
Manier, Salomon
Baz, Rachid
Raab, Marc
Cavo, Michele
Callander, Natalie
Costa, Luciano
Moreau, Philippe
Solomon, Scott
Chen, Christine
Raje, Noopur
Scheid, Christoph
Delforge, Michel
Larsen, Jeremy
Pabst, Thomas Mueller
Suzuki, Kenshi
Truppel-Hartmann, Anna
Yang, Zhihong
Piasecki, Julia
Felten, Jasper
Caia, Andrea
Cook, Mark
Giralt, Sergio
Mateos, Maria-Victoria
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S56 - S57
[6] Idecabtagene Vicleucel (Ide-Cel) Versus Standard Regimens (SRs) in Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Sub-Analysis of Black Patients
Patel, Krina K.
Rodriguez-Otero, Paula
Nooka, Ajay K.
Callander, Natalie S.
Solomon, Scott R.
Baz, Rachid
Sborov, Douglas W.
Gergis, Usama
Badros, Ashraf Z.
Giralt, Sergio A.
Pearse, Roger
Abonour, Rafat
Siegel, David S.
Larson, Sarah M.
Munshi, Nikhil C.
Truppel-Hartmann, Anna
Bhatnagar, Rashmi
Wu, Fan
Piasecki, Julia
Felten, Jasper
Caia, Andrea
Cook, Mark
Mckiver, Mihaela Popa
Jagannath, Sundar
Ailawadhi, Sikander
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S551 - S552
[7] Idecabtagene vicleucel (ide-cel) vs standard regimens in patients (pts) with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): a KarMMa-3 analysis in high-risk subgroups
Raab, Marc S.
Patel, Krina
Rodriguez-Otero, Paula
Manier, Salomon
Baz, Rachid
Cavo, Michele
Callander, Natalie
Costa, Luciano J.
Moreau, Philippe
Solomon, Scott R.
Chen, Christine
Raje, Noopur
Scheid, Christoph
Delforge, Michel
Larsen, Jeremy
Pabst, Thomas
Suzuki, Kenshi
Truppel-Hartmann, Anna
Piasecki, Julia
Felten, Jasper
Caia, Andrea
Cook, Mark
Giralt, Sergio
Mateos, Maria-Victoria
ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 144 - 144
[8] Idecabtagene vicleucel (Ide-cel) versus standard regimens in patients (pts) with Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 a Phase 3 Randomized Controlled Trial (RCT)
Scheid, C.
Rodriguez, Otero P.
Ailawadhi, S.
Arnulf, B.
Patel, K.
Cavo, M.
Nooka, A. K.
Manier, S.
Callander, N.
Costa, L. J.
Vij, R.
Bahlis, N. J.
Moreau, P.
Solomon, S. R.
Delforge, M.
Berdeja, J.
Truppel-Hartmann, A.
Favre-Kontula, L.
Wu, F.
Piasecki, J.
Cook, M.
Giralt, S.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 79 - 80
[9] Idecabtagene vicleucel (ide-cel) versus standard regimens in patients (pts) with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): a KarMMa-3 analysis in the modified intent-to-treat (mITT) population
Scheid, Christoph
Manier, Salomon
Ailawadhi, Sikander
Rodriguez-Otero, Paula
Arnulf, Bertrand
Patel, Krina
Solomon, Scott R.
Baz, Rachid
Jagannath, Sundar
Raje, Noopur
Mateos, Maria-Victoria
Abdallah, Al-Ola
Einsele, Hermann
Giralt, Sergio
Pabst, Thomas
Perrot, Aurore
Lin, Yi
Truppel-Hartmann, Anna
Bhatnagar, Rashmi
Felten, Jasper
Caia, Andrea
Piasecki, Julia
Cook, Mark
Moreau, Philippe
ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 142 - 142
[10] Idecabtagene vicleucel (ide-cel) vs standard regimens in patients with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 subgroup analysis by prior lines of therapy
Manier, Salomon
Rodriguez-Otero, Paula
Mateos, Maria-Victoria
Einsele, Hermann
Bahlis, Nizar
Munshi, Nikhil
Ailawadhi, Sikander
Arnulf, Bertrand
Nooka, Ajay
Vij, Ravi
Abrahamsen, Ingerid Weum
Broijl, Annemiek
Jagannath, Sundar
Benjamin, Reuben
Gergis, Usama
Sborov, Douglas
Iida, Shinsuke
Truppel-Hartmann, Anna
Yang, Zhihong
Bhatnagar, Rashmi
Piasecki, Julia
Felten, Jasper
Caia, Andrea
Cook, Mark
Baz, Rachid
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S50 - S51

← 1 2 3 4 5 →